ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,803, issued on Nov. 11, was assigned to Pfizer Inc. (New York).
"BCKDK inhibitors and/or degraders" was invented by Leanne Marie Buzon (Stonington, Conn.), Kimberly O'Keefe Cameron (Niantic, Conn.), Kevin Francis Deboyace (Mystic, Conn.), Kevin James Filipski (Reading, Mass.), David Andrew Griffith (Sudbury, Mass.), Bethany Lyn Kormos (Somerville, Mass.), Shenping Liu (Waterford, Conn.), Luis Angel Martinez Alsina (Gales Ferry, Conn.), Matthew Richard Reese (Mystic, Conn.), Rachel Jane Roth Flach (Rockland, Mass.) and Yuan Zhang (Mansfield, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula I,wherein the v...